At the Ivy Center, we're focused on bringing patients cutting-edge treatments, combining therapies to overcome tumor resistance, and proving what works through advanced clinical trials—delivering the future of brain tumor care today.

🌐 IvyBrainTumorCenter.org

Join us at the Ivy Center for a firsthand look at the future of brain tumor research. Take a tour of our cutting-edge facility & see how our Phase 0 approach is making a difference for patients. Reserve your spot now by emailing us!

📅: 3/11/25
⏰: 10-11:30 AM
📩: info@ivybraintumorcenter.org

In honor of International Day of Women & Girls in Science, we celebrate the incredible women & girls in science, who are making strides in research & innovation. Here's to the women making a difference & paving the way for future generations! 🔬💗 #WomenInScience #GirlsInSTEM

The Ivy Center is expanding its global Phase 3 Gliofocus Study for #GBM patients with the activation of new sites in the U.S. & EU: NeuroMedical Center, @ucsdhealth.bsky.social, @pitiesalpetriere.bsky.social & Hospital Universitario 12 de Octubre. 🧠

📰 Read the full press release: loom.ly/03Wumzo

📢The Gliofocus Study is now open in the EU! Led by Dr. Mehdi Touat in Paris and Dr. Juan Manuel Sepulveda Sanchez in Madrid, this Phase 3 clinical trial compares niraparib to TMZ in nGBM. 68 EU medical centers are in the global Gliofocus Study network. 🔗Gliofocus.org

There is hope for #braincancer patients. The Ivy Center is leading the way in #braintumor research & treatment. Learn more ➡️ IvyBrainTumorCenter.org

After 6 years of being involved in early phase clinical trials, I was honored to present data from our Phase 0/2 study exploring CDK4/6i +ERKi in rGBM patients. Grateful to the collaborative team, patients and their families #SNO2024

Dr. An-Chi Tien from Ivy Center will be presenting compelling results from our Phase 0/1 study of BDTX-1535 in recurrent GBM patients with EGFR alterations at #SNO2024.

📍 Stop by the Poster Session in Hall B3, or explore our research at loom.ly/ciiEqXY 🧠